Shanghai Xinzhi Biomed Co., Ltd.

This study tests a single-dose gene therapy called BBM-H901 in 32 adults with severe hemophilia B. The treatment uses a harmless virus to deliver a working gene that helps the body produce its own clotting factor, potentially reducing or preventing bleeding episodes. Researchers …